Prokidney (PROK) Non-Current Assets (2021 - 2026)
Prokidney's (PROK) quarterly Non-Current Assets came in at $59.2 million in Q2 2026, up 24.23% year-over-year from $47.7 million in Q2 2025, and up 2.36% quarter-over-quarter from $57.9 million in Q1 2026.
Analysis
Prokidney (PROK) Non-Current Assets (2021 - 2026) Analysis & Trends
Prokidney (PROK) has reported Non-Current Assets for 6 consecutive years, with $59.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Assets rose 24.23% year-over-year to $59.2 million in Q2 2026; TTM through Jun 2026 was $223.6 million, a 21.65% increase from a year earlier, with the FY2025 full-year figure at $54.9 million, up 21.48% from the prior year.
- Non-Current Assets was $59.2 million for Q2 2026 at Prokidney, up from $57.9 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $250.4 million in Q2 2022 and troughed at $13.1 million in Q3 2022.
- A 5-year average of $64.2 million and a median of $47.0 million in 2023 frame the typical range for Non-Current Assets.
- The widest YoY moves for Non-Current Assets: up 65845.09% in 2022, down 94.77% in 2022.
- Over 5 years, Non-Current Assets stood at $13.3 million in 2022, then soared by 249.52% to $46.4 million in 2023, then dropped by 2.62% to $45.2 million in 2024, then climbed by 21.48% to $54.9 million in 2025, then gained by 7.93% to $59.2 million in 2026.
- The last three Non-Current Assets figures came in at $59.2 million (Q2 2026), $57.9 million (Q1 2026), and $54.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 441.00 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 279.00 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 451.27 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 523.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 150.83 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 207.76 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 35.91 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 964.69 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 238.14 Mn |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - | 59.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.25 Mn |
| Mar 31, 2026 | 57.88 Mn |
| Dec 31, 2025 | 54.90 Mn |
| Sep 30, 2025 | 51.62 Mn |
| Jun 30, 2025 | 47.69 Mn |
| Mar 31, 2025 | 46.40 Mn |
| Dec 31, 2024 | 45.19 Mn |
| Sep 30, 2024 | 44.57 Mn |
| Jun 30, 2024 | 48.90 Mn |
| Mar 31, 2024 | 47.61 Mn |
| Dec 31, 2023 | 46.41 Mn |
| Sep 30, 2023 | 45.38 Mn |
| Jun 30, 2023 | 17.79 Mn |
| Mar 31, 2023 | 15.01 Mn |
| Dec 31, 2022 | 13.28 Mn |
| Sep 30, 2022 | 13.07 Mn |
| Jun 30, 2022 | 250.37 Mn |
| Mar 31, 2022 | 250.16 Mn |
| Dec 31, 2021 | 13.03 Mn |
| Sep 30, 2021 | 250.00 Mn |